CA2488397C - Forme cristalline ii de la clarithromycine - Google Patents

Forme cristalline ii de la clarithromycine Download PDF

Info

Publication number
CA2488397C
CA2488397C CA002488397A CA2488397A CA2488397C CA 2488397 C CA2488397 C CA 2488397C CA 002488397 A CA002488397 A CA 002488397A CA 2488397 A CA2488397 A CA 2488397A CA 2488397 C CA2488397 C CA 2488397C
Authority
CA
Canada
Prior art keywords
methylerythromycin
solvent
syrup
isolating
semisolid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002488397A
Other languages
English (en)
Other versions
CA2488397A1 (fr
Inventor
Jih-Hua Liu
David A. Riley
Stephen G. Spanton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BGP Products Operations GmbH
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32851609&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2488397(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/681,723 external-priority patent/US5858986A/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to CA002627035A priority Critical patent/CA2627035A1/fr
Priority claimed from CA002419729A external-priority patent/CA2419729C/fr
Publication of CA2488397A1 publication Critical patent/CA2488397A1/fr
Application granted granted Critical
Publication of CA2488397C publication Critical patent/CA2488397C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La présente invention concerne de nouvelles formes cristallines I et II de la b-O-méthylérythromycine A. Ces composés ont une activité antibiotique.
CA002488397A 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine Expired - Lifetime CA2488397C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002627035A CA2627035A1 (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/681,723 1996-07-29
US08/681,723 US5858986A (en) 1996-07-29 1996-07-29 Crystal form I of clarithromycin
CA002419729A CA2419729C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002419729A Division CA2419729C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002627035A Division CA2627035A1 (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine

Publications (2)

Publication Number Publication Date
CA2488397A1 CA2488397A1 (fr) 1998-02-05
CA2488397C true CA2488397C (fr) 2008-07-08

Family

ID=32851609

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002471102A Expired - Lifetime CA2471102C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine
CA002488397A Expired - Lifetime CA2488397C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002471102A Expired - Lifetime CA2471102C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine

Country Status (1)

Country Link
CA (2) CA2471102C (fr)

Also Published As

Publication number Publication date
CA2471102A1 (fr) 1998-02-05
CA2471102C (fr) 2005-02-08
CA2488397A1 (fr) 1998-02-05

Similar Documents

Publication Publication Date Title
US5858986A (en) Crystal form I of clarithromycin
AU2001222619C1 (en) Processes for preparing clarithromycin polymorphs
AU783055B2 (en) Processes for preparing clarithromycin polymorphs and novel polymorph IV
CA2309963C (fr) Oxime de 6-o-alkyle erythromycine b
AU733646B2 (en) Preparation of crystal form II of clarithromycin
CA2488397C (fr) Forme cristalline ii de la clarithromycine
CA2386534C (fr) Forme cristalline ii de la clarithromycine et son utilite
CA2386527C (fr) Forme cristalline i de la clarithromycine
AU777612B2 (en) Crystal form I of clarithromycin
CN101812102B (zh) 6-o-甲基红霉素a晶型v
HK1089182A (en) Crystal form i of clarithromycin
ZA200204638B (en) Processes for preparing clarithromycin polymorphs and novel polymorph IV.
AU2005203314A1 (en) Processes for preparing clarithromycin polymorphs

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170725